Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

New York, Jan 28, 2026, 13:23 ET — Regular session

  • Roper shares dipped further, following a sharp decline linked to its 2026 guidance just a day earlier
  • The company reported weaker demand at Deltek, its government contracting software division
  • Traders are focused on Washington’s Jan. 31 funding deadline and a fresh wave of broker calls

Roper Technologies shares slipped roughly 2% in early afternoon trading Wednesday, as the software company’s 2026 forecast missed Wall Street expectations, pushing the stock lower. 1

This move matters since Tuesday’s guidance reset thrust Deltek back into the spotlight. Investors are now trying to figure out if the hiccup is just a blip or signals a prolonged slowdown in spending by U.S. agencies and government contractors.

Washington now faces yet another funding deadline this weekend, a risk Roper has flagged as a possible headwind for Deltek’s business.

Roper on Tuesday projected 2026 revenue growth around 8%, with adjusted earnings per share expected between $21.30 and $21.55—both figures coming in under analyst forecasts, per LSEG data cited by Reuters. The company also issued first-quarter adjusted EPS guidance of $4.95 to $5.00, falling short of estimates. 2

The company flagged weaker demand at Deltek, with Reuters noting management’s caution that future U.S. government shutdowns could weigh on the unit. Deltek saw a slowdown in September as agencies paused operations ahead of the latest shutdown. 2

Roper disclosed its fourth-quarter figures in an SEC filing, showing revenue at $2.06 billion and adjusted diluted EPS of $5.21. The company’s “adjusted” numbers exclude certain items it considers distortions to its core performance. 3

CEO Neil Hunn described the outlook as a “more appropriate and balanced” perspective, following a string of disappointing quarters tied to Deltek uncertainty, Reuters reported. 2

Broker updates keep coming. Stifel’s Brad Reback dropped the stock from “Buy” to “Hold” and slashed his price target from $550 to $385, according to StreetInsider. 4

The next move could swing either way. Should Deltek demand hold steady and agencies steer clear of another halt in contracting, investors might overlook a revenue miss. But if government activity stumbles again or license sales falter, the company’s hopes for a second-half rebound will face serious doubt.

Traders are focused on Capitol Hill as U.S. funding is set to expire at 12:01 a.m. Eastern on Saturday, Jan. 31. Reuters flagged the risk of a partial government shutdown if Congress fails to pass new funding. 5

Stock Market Today

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Singapore, Feb 7, 2026, 15:23 SGT — Market closed. Sembcorp Industries Ltd (SGX: U96) ended Friday down 0.33% at S$6.05, after trading between S$6.00 and S$6.05. About 4.3 million shares changed hands. 1 The stock goes into Monday’s session with two near-term markers that can move the narrative fast: full-year results later this month and the next steps on its planned push into Australia via Alinta Energy. Friday’s slip came as the broader Singapore market turned lower. The Straits Times Index fell 0.8%, snapping a three-day record run, The Business Times reported. 2 Sembcorp has scheduled its FY2025 results briefing
Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

7 February 2026
Hongkong Land shares fell 4.2% to US$8.18 in Singapore on Friday after the company disclosed a buyback of 170,000 shares at US$8.5252 each on Feb. 5, with plans to cancel them. The drop followed a volatile week marked by a new Singapore real estate fund launch and an expanded buyback programme. Investors are watching for the group’s annual results on March 5.
Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week
Previous Story

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Western Digital stock jumps 11% as storage shares rally on AI demand signals
Next Story

Western Digital stock jumps 11% as storage shares rally on AI demand signals

Go toTop